Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | 0.62% | 612.17 | 1.0% | $694.47m | |
| DHR | Danaher Corp. | 0.90% | 313.52 | 0.7% | $689.48m | |
| ABT | Abbott Laboratories | 1.39% | 126.79 | 0.8% | $672.08m | |
| MDT | Medtronic Plc | 1.13% | 123.02 | 0.6% | $552.77m | |
| ISRG | Intuitive Surgical, Inc. | 0.56% | 341.52 | 0.8% | $438.08m | |
| ALGN | Align Technology, Inc. | -1.49% | 590.56 | 6.3% | $335.66m | |
| BDX | Becton, Dickinson & Co. | 0.28% | 247.17 | 1.0% | $300.19m | |
| DXCM | DexCom, Inc. | -0.27% | 566.57 | 7.8% | $274.45m | |
| SYK | Stryker Corp. | -0.19% | 275.91 | 1.3% | $272.46m | |
| EW | Edwards Lifesciences Corp. | 0.76% | 116.62 | 0.4% | $266.76m | |
| BSX | Boston Scientific Corp. | -0.11% | 44.82 | 1.0% | $249.23m | |
| A | Agilent Technologies, Inc. | 0.60% | 157.88 | 1.6% | $217.19m | |
| IDXX | IDEXX Laboratories, Inc. | 1.02% | 651.85 | 3.8% | $213.59m | |
| BAX | Baxter International, Inc. | 0.90% | 82.19 | 1.8% | $187.14m | |
| INMD | InMode Ltd. | 0.64% | 84.48 | 0.0% | $180.38m |
Company Profile
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: GI Health, Minimally Invasive Interventions, Infusion Therapy, and Emerging Innovations. The GI health division comprises of EsoGuard esophageal DNA laboratory developed test, EsoCheck Esophageal Cell Collection Device, and EsoCure Esophageal Ablation Device with Caldus technology. The minimally invasive interventions division offers CarpX minimally invasive surgical device for carpal tunnel syndrome. The infusion therapy division includes PortIO implantable intraosseous vascular accedd device and NextFlo highly accurate disposable intravenous infusion platform technology. The emerging innovations divisions consists of non-invasive laser-based glucose monitoring, single-use ventilators, resorbable pediatric ear tubes and mechanical circulatory cannulas. The company was founded on June 26, 2014 and is headquartered in New York, NY.